Codexis (CDXS) Return on Invested Capital (2019 - 2020)
Codexis (CDXS) posted quarterly Return on Invested Capital of 6.22% for Q4 2020, down 600.0% year-over-year from 1.24% in Q1 2020, and down 279.9% quarter-over-quarter from 1.64% in Q3 2020.
Codexis (CDXS) Return on Invested Capital (2019 - 2020) Analysis & Trends
Codexis' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 6.22% for Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -6.22% |
| Sep 30, 2020 | -1.64% |
| Jun 30, 2020 | -0.53% |
| Mar 31, 2020 | -0.31% |
| Dec 31, 2019 | -0.22% |
| Sep 30, 2019 | -0.25% |
| Jun 30, 2019 | -0.44% |